genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Fibroblast growth factor
Cancer
GSK Ends Collaboration with Five Prime to Develop FP-1039
Industry News
Fibrocell, Intrexon to Co-Develop Fibroblasts for Joint Diseases, Including Arthritis
News
FGF 21 Protein May Play Key Role in Human Liver Regeneration
Insights
Corruption of the Tumor Microenvironment
Drug Discovery
Presto! Changing Skin Cells into Beating Heart Cells
Cancer
ArQule Regains Rights to AKT Inhibitor from Daiichi Sankyo
Insights
New Life for Embryonic Stem Cells
Insights
Look, No Label! Label-Free MST
News
Muscle Aging Linked to Stem Cell Overdrive
Drug Discovery
BMS Nabs Global Rights to Ambrx’ Fibroblast Growth Factor and Relaxin Candidates for $24M
1
2
3
4
5
Page 3 of 5
Scroll Up
Scroll Up
